Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Investor Group Takes Aim at Antibiotics, Demanding Changes From Fast-Food Companies
Concern over the rise of drug-resistant superbugs is spreading beyond hospital wards and health clinics to the world’s major financial centers. Source link
FDA's OK Isn't Always a Happy Day for Biotech Investors
In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link
The Accountant Shortage Is Showing Up in Financial Statements
Advance Auto Parts and others have cited a lack of skilled accounting personnel for material weaknesses in their financial-reporting controls, a key predictor of restatements.
FDA Approval Isn't Always a Happy Day for Biotech Investors
In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link
Europe Is Probing Whether Ozempic Use Raises Risk of Suicidal Thoughts
Ozempic is under review by European drug-safety regulators after they received reports of suicidal thoughts linked to the popular weight-loss drug and another medicine in
In Battle With Microsoft, Google Bets on Medical AI Program to Crack Healthcare Industry
The search giant is fine-tuning chatbot technology via medical licensing exams. Source link
The Job Market vs. Inflation
Federal Reserve rate increases haven’t cooled the job market or inflation as much as investors thought they would. Source link
Obesity Drugs Won't Starve These Other Potential Blockbusters
Stocks of developers of fatty liver disease treatments had been on a tear until results from Eli Lilly’s medication were published last week. Source link
Mallinckrodt in Talks to Cut Opioid Settlement by Up to $1 Billion
Mallinckrodt, the financially troubled pharmaceutical company, is in discussions with a compensation trust for opioid victims as it seeks to potentially reduce the amount of
FDA Approves Leqembi, Extending Alzheimer's Treatment to More Patients
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link